ALSAF Safe Orthopaedics SAS

EuroSpine 2016: Safe Orthopaedics invites five highly regarded surgeons to share their experiences of the benefits of its modular technologies

Regulatory News:

SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 – SAFOR), a company offering innovative ranges of sterile implants combined with their single-use instruments for back surgery, is announcing a stronger presence at this year’s EuroSpine Congress, which will be held in Berlin from October 5 to 7, 2016.

At this conference attended by world’s top experts in back surgery, five surgeons will share their experiences of the benefits of Safe Orthopaedics’ technology for MIS surgeries.

The five talks will be hosted by Safe Orthopaedics on its stand (booth no. 131):

Wednesday, October 5, 2016, 10.05am to 10.20am:

Dr. N. Craig, surgeon at Aberdeen Royal Infirmary and Woodend Hospital in the United Kingdom, will give a presentation entitled: Availability of sterile and single use platforms

From a surgeon’s perspective, Safe Orthopaedics’ technology minimizes the logistics time of the instrumentation cycle and increases availability for better patient care.

Wednesday, October 5, 2016, 3.25pm to 3.40pm:

Dr. J. Franke, a surgeon at Klinikum Dortmund in Germany, will give a presentation entitled: Cypress: The Modular Anchorage Screw, for Degenerative Surgeries

The Cypress screw dedicated to degenerative conditions allows a per-operative choice of surgical approach (MIS or open) and strengthens anchorage through secure cement injection.

Thursday, October 6, 2016, 10.05am to 10.20am:

Prof. J.-C. Le Huec, Chief of the Spinal Orthopedics-Traumatology unit at Bordeaux University Hospital, will give a presentation entitled: Walnut: The Modular Fixation Cervical Cage

How its pre-loaded screws and its intuitive instrumentation make Safe Orthopaedics’ new cervical cage an easy-to-use product that provides an excellent anatomical fixation.

Thursday, October 6, 2016, 3.25pm to 3.40pm:

Dr. S. Van Gaalen, a surgeon at Diakonessenhuis in Utrecht (Netherlands), will give a presentation entitled: Oak: The Percutaneous Auto-Correction Screw, for Trauma Surgeries

Safe Orthopaedics’ patented Oak screw technology combines the benefits for MIS surgery of the efficiency of monoaxial screws with the ease of use of polyaxial screws.

Friday, October 7, 2016, 10.05am to 10.20am:

Dr. R. Cincu, surgeon at Santa Lucia University General Hospital in Communidad (Spain), will give a presentation entitled: Modularity of Safe Orthopaedics’ technology

Safe Orthopaedics’ ancillary platforms give surgeons a per-operative choice of approach. While trauma surgery has already adopted the percutaneous approach, the MIS guidance for degenerative conditions requires appropriate and easier-to-use equipment, and that is precisely what Safe Orthopaedics offers.

Pierre Dumouchel, Chief Executive Officer of Safe Orthopaedics, said: “We are both proud and excited to see the growing interest among surgeons in Safe Orthopaedics, as reflected by these talks. By sharing their experiences of our products, they will demonstrate the relevance of our innovations firmly anchoring single-use instruments and MIS surgery at the heart of surgical practice.”

About Safe Orthopaedics

Founded in 2010, Safe Orthopaedics is a French medical technology company that develops and markets an innovative range of sterile implants and associated single-use surgical instruments, with the aim of facilitating safer, optimized and lower-cost spinal surgery. By avoiding the reuse of surgical instruments, Safe Orthopaedics reduces the risk of infection, avoids the cumbersome and unreliable logistics of instrument sterilization, and limits hospital costs. Protected by 17 patent families, the SteriSpine™ Kits are CE-marked and FDA cleared. The company is based at Eragny-sur-Oise (France), and has 34 employees. For more information, visit: www.SafeOrtho.com

EN
05/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Safe Orthopaedics SAS

Arnaud Riverain
  • Arnaud Riverain

SAFE ORTHOPAEDICS - CA T3 : Mieux sur les Ventes Directes mais l'incer...

CA T3 -19% (943 K€) / -33% à périmètre constant Ventes Directes +28% (618 K€) / -7% à périmètre constant Ventes Indirectes -52% (325 K€) Trésorerie au 30/09 de 575 K€ 

Arnaud Riverain
  • Arnaud Riverain

SAFE ORTHOPAEDICS - RN S1 : Optimisation des charges

Amélioration des résultats grâce à l’optimisation des charges externes CA S1 1,7 M€ (-15%), ROC -3,2 M€ vs -4 M€ au S1 2019, RN -3,5 M€ vs -4,1 M€ Trésorerie au 30/06 de 3,2 M€

Arnaud Riverain
  • Arnaud Riverain

SAFE ORTHOPAEDICS - CA S1 : Bonne résistance à la crise

CA S1 -15% à 1,7 M€ / T2 -32% Vente Directe -12,6% à 0,88 M€ Vente Indirecte -18% à 0,85 M€

Arnaud Riverain
  • Arnaud Riverain

Acquisition de LCI Medical confirmée

Modalités : 80% en numéraire / 20% en titres sur la base d’une valorisation de Safe Orthopaedics de 6,1 M€ 

 PRESS RELEASE

SafeOrthopaedics annonce le dépôt de plusieurs marques au Japon

ÉRAGNY-SUR-OISE, France--(BUSINESS WIRE)-- Regulatory News: Safe Orthopaedics (FR0013467123 – ALSAF) (Paris:ALSAF), société spécialisée dans la conception et la commercialisation de kits prêts à l’emploi, comprenant implants et instruments à usage unique, neufs et stériles, destinés au traitement mini-invasif des fractures du rachis, annonce l’acceptation de plusieurs dépôts de marques par l’office japonais. Le 7 mai 2020, à l’instar de la marque SteriSpine, Safe Orthopaedics a eu confirmation de l’acceptation de ses marques produits WALNUT, CEDAR, ELM, OAK et LARCH auprès de l’Office jap...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch